Abstract
Molluscan defense mechanisms are regulated to innate immunity, which is largely dependent on cellular components such as hemocytes possessing phagocytic and bactericidal activities. Among immune responses, apoptosis is an indispensable process because it enables the adequate clearance of damaged, senescent and infected cells without inflammation. Available information related to the molecular mechanisms of apoptosis has been accumulated for many molluscan species during the last decade. Almost all molluscan species live in an environment that changes incessantly according to microorganisms, industrial pollutants, temperature, and salinity. Such environmental factors might directly or indirectly induce apoptosis in molluscan cells. One type of apoptotic agent, reactive oxygen intermediates (ROIs), which are produced by a stress signal or phagocytosis, triggers apoptotic cell death in molluscan hemocytes. Dysfunction of ROI-mediated hemocytic apoptosis putatively causes disease morbidity and/or mortality when molluscan organisms are infected by pathogens. Furthermore, integrins have attracted attention for their unique functions because integrins regulate the phagocytic ability of molluscan hemocytes and induce hemocytic apoptosis. That process might be the result of ROI-generation. In this review, we summarize the roles and molecular mechanisms of apoptosis related to immunological functions of molluscan hemocytes.
Keywords: Apoptosis, molluscs, hemocyte, immunity, integrin, nitric oxide, reactive oxygen intermediates, phagocytosis
Current Pharmaceutical Design
Title: Mechanisms and Immunological Roles of Apoptosis in Molluscs
Volume: 14 Issue: 2
Author(s): Kazutaka Terahara and Keisuke G. Takahashi
Affiliation:
Keywords: Apoptosis, molluscs, hemocyte, immunity, integrin, nitric oxide, reactive oxygen intermediates, phagocytosis
Abstract: Molluscan defense mechanisms are regulated to innate immunity, which is largely dependent on cellular components such as hemocytes possessing phagocytic and bactericidal activities. Among immune responses, apoptosis is an indispensable process because it enables the adequate clearance of damaged, senescent and infected cells without inflammation. Available information related to the molecular mechanisms of apoptosis has been accumulated for many molluscan species during the last decade. Almost all molluscan species live in an environment that changes incessantly according to microorganisms, industrial pollutants, temperature, and salinity. Such environmental factors might directly or indirectly induce apoptosis in molluscan cells. One type of apoptotic agent, reactive oxygen intermediates (ROIs), which are produced by a stress signal or phagocytosis, triggers apoptotic cell death in molluscan hemocytes. Dysfunction of ROI-mediated hemocytic apoptosis putatively causes disease morbidity and/or mortality when molluscan organisms are infected by pathogens. Furthermore, integrins have attracted attention for their unique functions because integrins regulate the phagocytic ability of molluscan hemocytes and induce hemocytic apoptosis. That process might be the result of ROI-generation. In this review, we summarize the roles and molecular mechanisms of apoptosis related to immunological functions of molluscan hemocytes.
Export Options
About this article
Cite this article as:
Terahara Kazutaka and Takahashi G. Keisuke, Mechanisms and Immunological Roles of Apoptosis in Molluscs, Current Pharmaceutical Design 2008; 14 (2) . https://dx.doi.org/10.2174/138161208783378725
DOI https://dx.doi.org/10.2174/138161208783378725 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employ in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, prediction, to monitor of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal fluid ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more
Food-derived bioactive peptides against chronic diseases
Chronic diseases, such as cardiovascular diseases and metabolic diseases, have become a great threat to the human health in recent decades due to the excessive food consumption and the prevalence of sedentary lifestyle. As a class of natural compounds, food-derived bioactive peptides have been demonstrated to possess great potential for ...read more
Innovative delivery systems and formulations for the management of diseases affecting the skin and skin appendages
Skin and skin appendage diseases have high incidence and can highly impact the quality of life. Such diseases include pigmentation disorders, such as melasma, vitiligo and post-inflammatory hyperpigmentation, infectious diseases caused by fungi, viruses, bacteria and parasites, inflammatory diseases such as acne, dermatitis, rosacea, and psoriasis, as well as skin ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting Tumors with Small Molecule Peptides
Current Cancer Drug Targets Cancer Prevention with Promising Natural Products: Mechanisms of Action and Molecular Targets
Anti-Cancer Agents in Medicinal Chemistry Natural Products Chemistry in Marine Ascidians of the Genus Aplidium
Mini-Reviews in Organic Chemistry The Immunoproteasome: An Emerging Therapeutic Target
Current Topics in Medicinal Chemistry 86Y Based PET Radiopharmaceuticals: Radiochemistry and Biological Applications
Medicinal Chemistry Research of Active Compounds from <i>Allii Macrostemonis Bulbus</i> and Potential Targets against Non-Hodgkin’s Lymphoma Based on Network Pharmacology
Current Computer-Aided Drug Design Diffuse Large B-Cell Lymphoma Presenting as an Anterior Chest Wall Mass: A Case Report and Literature Review
Current Respiratory Medicine Reviews Gene Expression Signatures in Primary Immunodeficiencies: The Experience from Human Disease and Mouse Models
Current Molecular Medicine Chemometric Evaluation of the Significance of Molecular Structural Descriptors on Binding of Acridinone Derivatives to DNA
Letters in Drug Design & Discovery Respiratory Stem Cells and Progenitors: Overview, Derivation, Differentiation, Carcinogenesis, Regeneration and Therapeutic Application
Current Stem Cell Research & Therapy 2-Aminoimidazoles in Medicinal Chemistry
Mini-Reviews in Medicinal Chemistry Effects of Natural Compounds on Xenopus Embryogenesis: A Potential Read Out for Functional Drug Discovery Targeting Wnt/β-catenin Signaling
Current Topics in Medicinal Chemistry Endothelial Progenitor Cells: Hope Beyond Controversy
Current Cancer Drug Targets Pharmacokinetics and Disposition of Various Drug Loaded Liposomes
Current Drug Metabolism Glycogen Synthase Kinase-3: A Potential Target for Drug Discovery in the Treatment of Neurodegenerative Disorders
Current Enzyme Inhibition Review of Clinic Trials: Agents Targeting c-Met
Reviews on Recent Clinical Trials Endocrine Therapy Resistance: Current Status, Possible Mechanisms and Overcoming Strategies
Anti-Cancer Agents in Medicinal Chemistry Pre-feasibility Study for Establishing Radioisotope and Radiopharmaceutical Production Facilities in Developing Countries
Current Radiopharmaceuticals RNA-Mediated Therapeutics: From Gene Inactivation to Clinical Application
Current Topics in Medicinal Chemistry Exploitation of Apoptosis Pathways for Childhood Leukemia
Current Pediatric Reviews